tranexamic acid has been researched along with Carcinoma, Colloid in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present phase II trial, 26 heavily pretreated patients with advanced recurrent ovarian carcinoma were treated with tranexamic acid, 4-6 g per os daily for at least 3 months." | 7.66 | Tranexamic acid for the treatment of advanced ovarian carcinoma. ( Johnsson, JE; Sigurdsson, K; Tropé, C, 1983) |
| "In the present phase II trial, 26 heavily pretreated patients with advanced recurrent ovarian carcinoma were treated with tranexamic acid, 4-6 g per os daily for at least 3 months." | 3.66 | Tranexamic acid for the treatment of advanced ovarian carcinoma. ( Johnsson, JE; Sigurdsson, K; Tropé, C, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sigurdsson, K | 1 |
| Johnsson, JE | 1 |
| Tropé, C | 1 |
1 other study available for tranexamic acid and Carcinoma, Colloid
| Article | Year |
|---|---|
Tranexamic acid for the treatment of advanced ovarian carcinoma.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Adult; Aged; Carcinoma; Cyclohexanecarboxylic Acids; Drug | 1983 |